Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis

Author： Lee Yonghyun   Kim Hyunjeong   Kim Wooseong   Yoon Jeong-Hyun   Jeong Seong Hoon   Jung Yunjin  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.20, Iss.6, 2012-07, pp. : 524-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical pharmacology of celecoxib, a COX-2 selective inhibitor

By Antoniou Katerina   Malamas Michael   Drosos Alexandros A  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1719-1732

Informa Healthcare

Access to resources Recommend Favorite

Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis

By Davies N.M.   Gudde T.W.   de Leeuw M.A.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 139-152

Informa Healthcare

Access to resources Recommend Favorite

Dextran Carrier Macromolecule for Colon Specific Delivery of Celecoxib

By  

Current Drug Delivery, Vol. 7, Iss. 2, 2010-04 ,pp. : 144-151

Bentham Science Publishers

Access to resources Recommend Favorite

Calcium Pectinate Capsules for Colon-Specific Drug Delivery

By Xu Chen   Tan Ren Xiang   Zhang Jun Shou   Mo Yun  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 2, 2005-02 ,pp. : 127-134

Informa Healthcare

Access to resources Recommend Favorite

Colon-specific drug delivery for mebeverine hydrochloride

By Omar Samia   Aldosari Basmah   Refai Hanan   Gohary Omaimah Al  

Journal of Drug Targeting, Vol. 15, Iss. 10, 2007-12 ,pp. : 691-700

Informa Healthcare

Access to resources Recommend Favorite